AI medical stock landing MASSIVE contracts

Dear Reader, Few people know its name, but Intuitive Surgical was one of the five best stocks of the last 20 years. It went up as much as 18,000% in two decades. Why? Because it used new technology - surgical robotics - to drive sales sky high. Now... another company is following its path. The company is tiny today - just $500 million - but it is in position to grow dramatically. In short, it is the inventor of the world's first AI-designed drug to enter clinical trials. And big pharma is lining up to use its patent-protected technology.        Merck is collaborating with them on three projects that could generate up to $674 million in revenue.        French pharma giant Sanofi agreed to pay the company up to $5.2 billion to develop 15 new drugs.        Bristol Meyers Squibb signed a $1.2 billion partnership with the company. You can see... each one of these projects is worth more than the entire market cap of this new AI stock! In short, the upside is MASSIVE. Which is why I wanted to send you this video. It comes from one of the great stock pickers of all-time - a man who actually recommended Intuitive Surgical in real time back in 2004. In fact, he called 4 of the top 6 performing stocks from 2000 to 2020. And he says this new company is the #1 AI Stock Under $10. Watch his free video breaking down the situation here. Sincerely, Rachel Gearhart Associate Publisher, The Oxford Club Advertising Disclosure: This email contains paid advertisements. Legal Entity Information: Premium Market News is a website owned and operated by Darwin Investor Network, which is a DBA of The Darwin Agency, Inc. The above is a paid advertisement. If you do not wish to receive this email, then we apologize for the inconvenience. You can immediately discontinue receiving this email by clicking on the unsubscribe or profile link and you will no longer receive this email. We will immediately redress any complaints you may have. If you have any questions, please send an email with your questions to support@premiummarketnews.com. Nothing in this email should be considered personalized financial advice. We strongly urge you to read our full disclaimer here. This Email is From Our Associates At Oxford Club If you can't see this message, view it in your browser. You are receiving this e-mail at edwardlorilla1986.paxforex@blogger.com as a part of your free subscription to the Premium Market News E-Letter. To read our privacy policy follow this link. or If you do not want to receive emails from us, you can follow this link to unsubscribe. To unsubscribe by mail, write us at: Premium Market News | 2319 N Andrews Ave Fort Lauderdale, FL 33311 Website: Premium Market News Advertising Disclosure: This email contains paid advertisements. Nothing in this email should be considered personalized financial advice. Staff members at Premium Market News are not qualified to answer your investing-related questions as they are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Copyright 2023 Premium Market News. All rights reserved.

-
In order to unsubscribe from this mailing list, please click here